Balentine LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-16
Closed -$2K 172
2020
Q2
$2K Sell
16
-112
-88% -$14K ﹤0.01% 825
2020
Q1
$14K Buy
+128
New +$14K ﹤0.01% 314